Navigation Links
ClearCanvas Releases First Commercial Version of Popular Clinical Radiology Workstation; PACS and RIS to Follow
Date:4/15/2011

TORONTO, April 15, 2011 /PRNewswire/ -- ClearCanvas Inc., an innovative medical imaging informatics company, today announced the commercial release of their clinical radiology workstation product, ClearCanvas Workstation, Clinical Edition. This marks the first time ClearCanvas has offered a commercial version of their widely accepted Workstation software, previously only offered as an open source application.

ClearCanvas open source software has been employed for over five years, with more than 14,000 worldwide users in a number of clinical settings. With such extensive application, commercial versions of the products were an obvious next step. ClearCanvas RIS/PACS recently received FDA 510(k) clearance. This important regulatory status allows for commercial distribution of the ClearCanvas software.

The ClearCanvas Workstation, Clinical Edition is available for purchase from the eStore on the ClearCanvas website as well as through a small but rapidly growing number of resellers worldwide.

ClearCanvas expects to release a commercial version of their PACS software suite in Q2 2011 with the commercial release of their RIS following in Q4 2011. Additional versions of the Workstation are already planned for 2011; product upgrades and technical support are included free of charge during the first license year. ClearCanvas will continue to release new versions of their open source software as well.  

"Open source products have always been an integral part of who we are and that will not change," states Norman Young, company President and Founder. "At the same time, we also recognize how important it is to create a vibrant commercial ecosystem by bringing our products to different markets around the world. We are extremely excited to offer what so many of our users have been asking for -- a commercial, FDA-cleared version of our very popular Workstation product."

About ClearCanvas Inc.

ClearCanvas Inc. develops innovative and easy-to-use medical imaging informatics software including clinical workstations, PACS, and RIS. ClearCanvas products are used worldwide by more than 14,000 clinicians, researchers, and developers. Their open source applications are freely available and their commercial applications deliver good value at a fair price. To learn more, visit http://www.clearcanvas.ca.

Contact:

Mary Burrell
Director, Technical Sales & Marketing
+1.970.372.6631
mary@clearcanvas.ca

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE ClearCanvas Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioLegend Releases Brilliant Violet 421™ Antibody Conjugates For Advanced Flow Cytometry Applications.
2. ACO Proposed Rule Simplified: MedeAnalytics Releases Comprehensive White Paper
3. Clontech Laboratories, Inc. Releases the SMARTer™ Ultra Low RNA Kit for Illumina® Sequencing
4. OriGene Releases Bioactive Full-length Human MTOR Protein
5. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011
6. Waters Releases NuGenesis SDMS 7.1 Validated to Support Windows 7 and Empower 3 CDS
7. OriGene Releases 1500 TrueMAB™ Monoclonal Antibodies
8. ACTE Releases Issue Brief Outlining Critical Role CTE Plays in Worker Retraining
9. Elsevier Releases Image Search; New SciVerse ScienceDirect Feature Enables Researchers to Quickly Find Reliable Visual Content
10. Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information
11. Kibow Biotech Releases Results of Pilot Scale Study of Its Probiotic Formulation for Kidney Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 22, 2017 MarketNewsUpdates.com News Commentary  ... The traditional ... being pressured as of late due to the rise of ... has a dramatic impact on patient,s quality of life as ... for identifying new forms of opioid formulations that prevent abuse. ...
(Date:3/22/2017)... , March 22, 2017   Boston Biomedical , ... therapeutics designed to target cancer stemness pathways, today announced ... Andrews as Chief Executive Officer, effective April 24, ... Chiang J. Li , M.D., FACP, who has led ... ago. Under his leadership, Boston Biomedical has grown from ...
(Date:3/22/2017)... ... ... Premier executive recruitment firm, Slone Partners, is proud to have been named a Top ... Hunt Scanlon Media is one of the most respected life science publications in the ... sector. , “It is a great honor for Slone Partners to be part of ...
(Date:3/22/2017)... ... March 21, 2017 , ... Proper glycosylation is critical for ... increase and/or decrease in antibody-dependent cellular cytotoxicity or complement-dependent cytotoxicity, there is a ... , To meet this demand, the team at SCIEX has developed a ...
Breaking Biology Technology:
(Date:3/9/2017)... SAN FRANCISCO and MOUNTAIN VIEW, ... Zipongo , "Eating Well Made Simple," and 23andMe ... to help guide better food choices.  Zipongo can now ... only their food preferences, health goals and biometrics, but ... to certain food choices. Zipongo,s personalized food ...
(Date:3/6/2017)... SAN MATEO, Calif. , March 6, 2017 ... predictive marketing and sales technology, today announced Predictive ... (AI) solution for infusing actionable sales intelligence into ... customers to automatically enable their sales organizations with ... contextual messages that allow for intelligent engagement. Predictive ...
(Date:3/2/2017)... -- Who risk to be deprived of its imprint ... https://www.reportbuyer.com/product/4313699/ WILL APPLE AND SAMSUNG CONFRONT ... sensors using capacitive technology represent a fast growing market, ... an increase of 360% of the number of fingerprint ... sensor market between 2014 and 2017 (source : N+1 ...
Breaking Biology News(10 mins):